James Xu is a partner in Goodwin’s Technology Companies & Life Sciences group. Mr. Xu’s practice concentrates on capital markets transactions, focusing on initial public offerings, as well as securities law reporting and compliance. In his practice, Mr. Xu represents a wide variety of companies and investment banks in the technology and life sciences industries. In addition, Mr. Xu counsels clients in private financings, mergers and acquisitions, governance and other general corporate matters. He joined Goodwin in 2010.